TGF-β1 Drives Stem Cell Aging Through DNA Methylation in Periodontal Tissue

This groundbreaking study reveals how TGF-β1 signaling drives aging in periodontal ligament stem cells (PDLSCs), which are crucial for maintaining healthy teeth and gums throughout life. As these stem cells age and lose function, they contribute to periodontal disease, which affects up to 90% of the global population and is linked to cardiovascular disease, diabetes, and cognitive decline.

Using cutting-edge spatial transcriptomics, researchers created the first detailed map of gene expression in mouse jawbone tissue. They discovered that TGF-β1 was highly enriched in the periodontium and showed increasing expression over time, suggesting a role in age-related changes.

In laboratory studies with human periodontal stem cells, TGF-β1 treatment triggered a cascade of aging-related changes. The protein increased DNA methyltransferase enzymes, which silenced the PRKAG2 gene encoding AMPKγ2. This silencing led to accumulation of reactive oxygen species (ROS), DNA damage, and activation of ATM signaling pathways that cause cells to stop dividing and enter senescence.

Crucially, the researchers demonstrated that this aging process could be reversed. Treatment with the antioxidant N-acetyl-L-cysteine (NAC) reduced ROS levels, while the DNA methylation inhibitor decitabine restored PRKAG2 expression. Both interventions prevented TGF-β1-induced senescence, suggesting potential therapeutic targets.

These findings illuminate a previously unknown mechanism linking TGF-β1 signaling, epigenetic regulation, and stem cell aging. The work provides a foundation for developing treatments that could maintain periodontal stem cell function with age, potentially preventing tooth loss and associated systemic health problems.